<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02364973</url>
  </required_header>
  <id_info>
    <org_study_id>T31/2014</org_study_id>
    <nct_id>NCT02364973</nct_id>
  </id_info>
  <brief_title>Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study</brief_title>
  <official_title>Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of the present study is to examine the diagnostic performance of combined&#xD;
      PET-MRI in detecting colonic and small bowel wall inflammatory processes caused by ulcerative&#xD;
      colitis and Crohn's disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COMBINED PET-MRI IN THE DIAGNOSTICS OF CHRONIC INFLAMMATORY BOWEL DISEASES (IBD)- A&#xD;
      FEASIBILITY STUDY (RESEARCH CODE T31/2014)&#xD;
&#xD;
        1. Background&#xD;
&#xD;
           Ulcerative colitis and Crohn's disease are chronic inflammatory bowel diseases (IBD)&#xD;
           with relapsing and remitting course. The incidence of IBD is highest in teenagers and&#xD;
           young adults, but IBD may also affect children and old people. The diagnosis of IBD is&#xD;
           based on clinical symptoms, endoscopy and histology of the bowel wall.&#xD;
&#xD;
           Aims of the study&#xD;
&#xD;
           The main purpose of the present study is to examine the diagnostic performance of&#xD;
           combined PET-MRI in detecting colonic and small bowel wall inflammatory processes caused&#xD;
           by ulcerative colitis and Crohn's disease.&#xD;
&#xD;
           The hypothesis of the study is a) IBD-related inflammatory changes are detected by&#xD;
           PET-MRI (18 F-FDG) and correlate with the endoscopic and histologic activity of colitis&#xD;
           and ileitis.&#xD;
&#xD;
           Study design&#xD;
&#xD;
           A total of 45 IBD patients (ulcerative colitis or Crohn's disease) aged over 15 years&#xD;
           will be recruited from the patients visiting outpatient gastroenterology clinic of Turku&#xD;
           University Hospital. Every patient undergoes colonoscopy with biopsy specimens,&#xD;
           endoscopic and histologic data are recorded via structured forms. Laboratory specimens&#xD;
           with samples for biobank are obtained. Then the patients are examined by abdominal MRI&#xD;
           and PET.&#xD;
&#xD;
           Inclusion criteria:&#xD;
&#xD;
             -  informed consent obtained&#xD;
&#xD;
             -  age over 18 years&#xD;
&#xD;
             -  diagnosis of ulcerative colitis or Crohn's colitis based on endoscopy and histology&#xD;
&#xD;
             -  the activity of colitis confirmed by histology and/or elevated fecal calprotectin&#xD;
                concentration&#xD;
&#xD;
             -  fertile women have contraception&#xD;
&#xD;
             -  no previous abdominal surgery&#xD;
&#xD;
             -  no X-ray investtigations during preceding year&#xD;
&#xD;
        2. Investigators&#xD;
&#xD;
           Principal investigator Markku Voutilainen, MD, Department of Gastroenterology&#xD;
&#xD;
           Other investigators Hannu Aronen, Sami Kajander, Johanna Virtanen, Virva Saunavaara,&#xD;
           Department of Radiology and PET center.&#xD;
&#xD;
           Mervi Tenhami, Saila Kauhanen, Department of surgery&#xD;
&#xD;
           Pirjo Nuutila, Department of Endocrinology and PET center&#xD;
&#xD;
           Jukka Kemppainen, physicist, PET center&#xD;
&#xD;
           Olli Carpen, Department of pathology&#xD;
&#xD;
           Ville Aalto, statistician, University of Turku,&#xD;
&#xD;
        3. PET tracer is 18 F-FDG, dose 280 megabequerel (MBq, bowel imaging)&#xD;
&#xD;
        4. Data of scans and details of scanning time (including positioning and transmission) by&#xD;
           tracer, blood sampling (activity, metabolites)&#xD;
&#xD;
             -  Before scanning: oral contrast intake (Mannitol dilution) 65 min&#xD;
&#xD;
             -  Magnetic resonance imaging (MRI) positioning (prone position) 5min&#xD;
&#xD;
             -  Abdominal MRI Scanning: 50min&#xD;
&#xD;
             -  Region: from diaphragma to symphysis&#xD;
&#xD;
             -  During the scan: i.v. Buscopan and +Gadolinium&#xD;
&#xD;
             -  Sequences (fast gradient echo, predominantly breath-hold imaging):&#xD;
&#xD;
                  1. T2 (field echo type) cor and ax&#xD;
&#xD;
                  2. T2&#xD;
&#xD;
                  3. T1 fs cor and ax +Gd&#xD;
&#xD;
                  4. T1 fs repeated (start at 40 seconds after injection)&#xD;
&#xD;
                  5. Diffusion&#xD;
&#xD;
                  6. T2 or T1 cor +aks&#xD;
&#xD;
             -  PET, FDG tracer: 15 min&#xD;
&#xD;
                  -  Total scanning time including positioning, MRI and PET: 70 min&#xD;
&#xD;
           Scanning code JN5JS (= Large scale PET-MRI of the body)&#xD;
&#xD;
        5. Number of study subjects 45&#xD;
&#xD;
        6. Scanner PET/MRI&#xD;
&#xD;
        7. The radiation dose will be calculated by physicist after the tracer, it's amount and&#xD;
           detector are determined. The permission from ethical committee was obtained in August&#xD;
           2014..&#xD;
&#xD;
        8. No quality issues (QA), routine radiological quality control&#xD;
&#xD;
        9. The study has been accepted by the Ethical committee of Turku University Hospital&#xD;
&#xD;
       10. Present study is academic study and all data relating to the study belongs to the&#xD;
           investigators.&#xD;
&#xD;
       11. The test patients are to undergo the study in September 2014. The study is to be started&#xD;
           October 2014.&#xD;
&#xD;
       12. For the financing of the study, VTR-/EVO-funding (Funding from the Finnish government)&#xD;
           will be applied. At present, 6000â‚¬ have been obtained from research funding of&#xD;
           Department of internal medicine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Actual">August 2020</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients with active inflammation detected by PET-MRI</measure>
    <time_frame>3 YEARS</time_frame>
    <description>COMBINED PET-MRI IN THE DIAGNOSTICS AND FOLLOW-UP OF CHRONIC INFLAMMATORY BOWEL DISEASES</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>IBD</condition>
  <arm_group>
    <arm_group_label>PET-MRI</arm_group_label>
    <description>Patients with chronic inflammatory bowel disease who are treated at Turku University hospital outpatient clinic or ward</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PET-MRI</intervention_name>
    <description>The study patients undergo positron emission tomography (PET) after informed consent is obtained</description>
    <arm_group_label>PET-MRI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        IBD patients living in the Turku University Hospital referral area&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  age over 18 years&#xD;
&#xD;
          -  IBD (ulcerative colitis or Crohn's disease diagnosed by endoscopy and/or radiology&#xD;
&#xD;
          -  no previous abdominal surgery&#xD;
&#xD;
          -  no biological therapy for IBD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  the patient is unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markku Voutilainen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 3, 2014</study_first_submitted>
  <study_first_submitted_qc>February 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2015</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

